REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
US INFECTIOUS DISEASE 2007 - ISSUE II - NOVEMBER 2007 |
|
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Keith P Klugman, MB, BCh, PhD, FRCPath (Lond) Member-at-Large, Executive Committee
International Society of Infectious Diseases (ISID)
|
HIV & AIDS
|
|
A Promising New Therapy for HIV Infection—Integrase Inhibitor
Sidonie A Morrison, PhD1 and Roy T Steigbigel, MD2
1. Associate Professor of Medicine and Pharmacology
2. Professor of Medicine, Pathology, Microbiology, and Pharmacology, State University of New York at Stony Brook
|
|
|
Immunosuppressive Effects of Drug Therapies Common in HIV-infected Patients
David J Feola, PharmD, PhD1 and Alice C Thornton, MD2
1. Assistant Professor, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy
2. Associate Professor, Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky College of Medicine
|
|
|
Update on the Diagnosis and Monitoring of HIV-1 Infection
Angela Darko, MD,1 William Kabat, BS,2 Niel Constantine, PhD1,4 and Richard Y Zhao, PhD1,3,4
1. Department of Pathology
2. Chicago Children’s Memorial Hospital
3. Department of Microbiology-Immunology
4. Institute of Human Virology, University of Maryland School of Medicine
|
|
|
The Continuing Spread of HIV/AIDS in the Southern US
Han-Zhu Qian, MD, PhD1 and Sten H Vermund, MD, PhD2
1. Assistant Professor of Medicine and Core Scholar
2. Professor of Medicine and Director, Institute for Global Health, Vanderbilt University School of Medicine
|
Viral Infections
|
|
Treatment of Chronic Hepatitis B—When to Start, When to Stop, and When to Alter Therapy
Emmet B Keeffe, MD, MACP
Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine
|
|
|
Medical Options in the Event of an Influenza Pandemic
John H Beigel, MD
Staff Clinician, National Institute of Allergy and Infectious Diseases, National Institutes of Health
|
Respiratory Syncytial Virus
|
|
Respiratory Syncytial Virus at 50
Leonard R Krilov, MD, FAAP
Chief of Pediatric Infectious Diseases and Vice Chairman of Pediatrics, Winthrop University Hospital, and Professor of Pediatrics, State University of New York at Stony Brook
|
|
|
Preventing Respiratory Syncytial Virus Infection—Where Is the Vaccine?
Joseph B Domachowske, MD
Department of Pediatrics, State University of New York Upstate Medical University
|
West Nile Virus
|
|
Diagnostic Features of West Nile Virus Infection for Clinical Physicians
Rajeev Vaidyanathan, PhD1,2 and Erol Fikrig, MD1
1. Department of Internal Medicine, Section of Rheumatology, Yale University School of Medicine
2. SRI CADRE Vector-borne and Zoonotic Disease Research
|
|
|
The Pathogenesis of West Nile Virus—Toward The Development of Effective Therapies and Vaccines
Michael S Diamond, MD, PhD
Departments of Medicine, Molecular Microbiology, Pathology, and Immunology, Washington University School of Medicine
|
|
|
West Nile Virus Eight Years Later—A Mosquito-borne Menace
Laura D Kramer, PhD
Director, Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, and Associate Professor, Department of Biomedical Sciences, School of Public Health, State University of New York, Albany
|
Bacterial Infections
|
|
Community-associated Methicillin-resistant Staphylococcus aureus— Overview of Our Current Understanding
Robert W Tolan, Jr, MD, FAAP, FIDSA
Chief, Division of Allergy, Immunology and Infectious Diseases, The Children’s Hospital at Saint Peter’s University Hospital, New Brunswick, and Clinical Associate Professor of Pediatrics, Drexel University College of Medicine, Philadelphia
|
|
|
The Importance of Controlling Methicillin-resistant Staphylococcus aureus
Samuel W Jones, MD and Bruce Cairns, MD, FACS
Department of Surgery, University of North Carolina-Chapel Hill
|
Infection Control
|
|
Infection Prevention and Control in the US—Current Status
Sue Sebazco, RN, BS, CIC
Infection Prevention/Employee Health Director, Arlington Memorial Hospital
|
|
|
Does a Double Layer of Surgical Gloves Enhance Infection Control Measures?
Denise M Korniewicz, PhD, RN, FAAN
Professor and Senior Associate Dean for Research, School of Nursing and Health Studies, University of Miami, and Professor, Department of Epidemiology, Miller School of Medicine, University of Miami
|
Technology & Services Section
|
|
Dangers of MRSA
Molnlycke Health Care
|
Reference Section
|
|
HIV-1 and Herpes Simplex Virus-2
Ryan King and Harvey M Friedman
|
|
|
Parainfluenza Viruses—New Epidemiology and Vaccine Developments
Stephen B Greenberg, MD, FACP1 and Robert L Atmar, MD, FACP2
1. Professor of Medicine, Dean of Medical Education;
2. Professor, Departments of Medicine and Molecular Virology & Microbiology,Baylor College of Medicine, Houston
|
|
|
Clostridium difficile-associated Diarrhea
Ali Hassoun, MD
Assistant Professor, Alabama Infectious Diseases Center, Huntsville
|
|
|
|
|
|
